“The Paradox of Predatory Pricing”

  • Intellectual Property and Antitrust
Cornell Law Review
2005

“Harmful Output in the Antitrust Domain: Lessons from the Tobacco Industry”

  • Intellectual Property and Antitrust
Georgia Law Review
2005

“Multiproduct Discounting A Myth of Nonprice Predation”

  • Intellectual Property and Antitrust
University of Chicago Law Review
2005

“The Perverse Effects of Predatory Pricing Law”

  • Intellectual Property and Antitrust
Regulation
2005

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
Genetics: Science, Ethics and Public Policy: A Reader
2005

“Ease Over Accuracy in Assessing Patent Settlements”

  • Intellectual Property and Antitrust
Minnesota Law Review
2004

“Obvious to Whom? Evaluating Inventions from the Perspective of PHOSITA”

  • Intellectual Property and Antitrust
Berkeley Technology Law Journal
2004

“Patenting Genome Research Tools and the Law”

  • Intellectual Property and Antitrust
Comptes rendus Biologies
2003

“Patent Swords and Shields”

  • Intellectual Property and Antitrust
Science
2003

“Reaching Through the Genome”

  • Intellectual Property and Antitrust
Perspectives on Properties of the Human Genome Project
2003

“Can Patents Deter Innovation? The Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Rights and Resources
2003

“Patents, Product Exclusivity, and Information Dissemination: How Law Directs Biopharmaceutical Research and Development”

  • Intellectual Property and Antitrust
Fordham Law Review
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
Law and Contemporary Problems
2003

“Bayh-Dole Reform and the Progress of Biomedicine”

  • Intellectual Property and Antitrust
American Scientist
2003

“Patents on DNA Sequences: Molecules and Information”

  • Intellectual Property and Antitrust
The Commodification of Information
2002

“The Role of Patents in Exploiting the Genome”

  • Intellectual Property and Antitrust
The Genomic Revolution: Unveiling the Unity of Life
2002

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
Who Owns Life?
2002

“How Can You Patent Genes?”

  • Intellectual Property and Antitrust
American Journal of Bioethics
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Can Patents Deter Innovation? The Anticommons in Biomedical Research”

  • Intellectual Property and Antitrust
Perspectives on Property Law
2002

“Why the Gene Patenting Controversy Persists”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
2002

“Public vs. Proprietary Science: A Fruitful Tension?”

  • Intellectual Property and Antitrust
Daedalus
2002

“Exit Payments in Settlement of Patent Infringement Lawsuits: Antitrust Rules and Economic Implications”

  • Intellectual Property and Antitrust
Florida Law Review
2002

“The Shifting Functional Balance of Patents and Drug Regulation”

  • Intellectual Property and Antitrust
Health Affairs
2001

“Bargaining Over the Transfer of Proprietary Research Tools: Is This Market Failing or Emerging?”

  • Intellectual Property and Antitrust
Expanding the Boundaries of Intellectual Property: Innovation Policy for the Knowledge Society
2001

“Analyze This: A Law and Economics Agenda for the Patent System”

  • Intellectual Property and Antitrust
Vanderbilt Law Review
2000

“Antitrust Settlements”

  • Intellectual Property and Antitrust
Settlement Agreements in Commercial Disputes Negotiating, Drafting and Enforcement
2000

“Ownership, Commercial Development, Transfer and Use of Publicly Funded Research Results: The United States Legal Regime”

  • Intellectual Property and Antitrust
The Role of Publicly Funded Research and Publicly Owned Technologies in the Transfer and Diffusion of Environmentally Sound Technologies
2000

“Re-Examining the Role of Patents in Appropriating the Value of DNA Sequences”

  • Intellectual Property and Antitrust
Emory Law Journal
2000

“Genomics in the Public Domain: Strategy and Policy”

  • Intellectual Property and Antitrust
Nature Reviews Genetics
2000

“Proprietary Rights and the Norms of Science in Biotechnology Research”

  • Intellectual Property and Antitrust
The Economics of Science and Innovation
2000

“The Promise and Perils of Strategic Publication to Create Prior Art: A Response to Professor Parchomovsky”

  • Intellectual Property and Antitrust
Michigan Law Review
2000

“Faith, Reason, and Bare Animosity”

  • Intellectual Property and Antitrust
Campbell Law Review
1999

“National Policy Perspectives-Streamlining the Transfer of Research Tools”

  • Intellectual Property and Antitrust
Academic Medicine: Journal of the Association of American Medical Colleges
1999

“Can Patents Deter Innovation? The Anticommons on Biomedical Research”

  • Intellectual Property and Antitrust
Science
1998

“Upstream Patents = Downstream Bottlenecks”

  • Intellectual Property and Antitrust
Law Quadrangle Notes
1998

“Do EST Patents Matter?”

  • Intellectual Property and Antitrust
Trends in Genetics
1998

“Genomic Patents and Product Development Incentives”

  • Intellectual Property and Antitrust
Human DNA: Law and Policy: International and Comparative Perspectives
1997

“Structure and Function in Gene Patenting”

  • Intellectual Property and Antitrust
Nature Genetics
1997

“Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored Research”

  • Intellectual Property and Antitrust
Virginia Law Review
1996

“Intellectual Property at the Public-Private Divide: The Case of Large-Scale cDNA Sequencing”

  • Intellectual Property and Antitrust
University of Chicago Law School Roundtable
1996

“Intellectual Property Issues in Genomics”

  • Intellectual Property and Antitrust
Trends in Biotechnology
1996

“Patents: Help or Hindrance to Technology Transfer?”

  • Intellectual Property and Antitrust
Biotechnology: Science, Engineering, and Ethical Challenges for the Twenty-First Century
1996

“Opinion Letter as to the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences”

  • Intellectual Property and Antitrust
AIPLA Quarterly Journal
1995

“Reply to Comments on the Patentability of Certain Inventions Associated with the Identification of Partial cDNA Sequences”

  • Intellectual Property and Antitrust
AIPLA Quarterly Journal
1995

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Law Quadrangle Notes
1994

“Technology Transfer and the Genome Project: Problems with Patenting Research Tools”

  • Intellectual Property and Antitrust
Risk: Health, Safety and Environment
1994

“A Technology Policy Perspective on the NIH Gene Patenting Controversy”

  • Intellectual Property and Antitrust
University of Pittsburgh Law Review
1994

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Chemtech
1993

“Limiting the Role of Patents in Technology Transfer”

  • Intellectual Property and Antitrust
Journal of NIH Research
1993